You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科興:接種第三針滅活疫苗 抗體可迅速提升十倍
阿思達克 06-07 07:51
據《央視新聞》報道,科興控股生物技術有限公司董事長尹衛東在接受《新聞1+1》採訪時表示,現時中國的滅活疫苗,兩針完成免疫以後,在體內已經建立起免疫記憶。最近已經完成了二期臨床研究,就是打完兩針劑次的志願者,在隔三個月六個月之後接種第三針,抗體可以迅速地在一周內跳到十倍,半個月就可以達到二十倍。但要在真實世界的研究過程中觀察,兩針疫苗持續保護效果有多長。

尹衛東還表示,將會在半年、一年進行詳細的研究測試,然後再建議國家應該在什麼時候加強第三針。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account